Morphochem

is a drug discovery research company that focuses on developing small-molecule drugs for the treatment of Clostridium difficile infection...
Read more
Morphochem CEO: Carsten Dehning

CEO

Carsten Dehning

CEO Approval Rating

78/100

Est. Annual Revenue
$5.0-25M
Agree?
Est. Employees
25-100
Agree?
Funding
$12.8M

Morphochem Competitors

1Second Genome
2Rebiotix
3Seres Therapeutics
4Vedanta
5Enterome
6MicroBiome Therapeutics, LLC
7MetaboGen
8Symbiotix Biotherapies
94D pharma
10Metabiomics

Trending Companies